Ticker
CTKBCompany Name
CYTEK BIOSCIENCES INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 15.2M | 7.75% | $ 196.03M |
3/31/2025 | $ 21.3M | 10.81% | $ 197.05M |
12/31/2024 | $ 25.38M | 12.66% | $ 200.45M |
9/30/2024 | $ 32.89M | 16.35% | $ 201.21M |
6/30/2024 | $ 15.43M | 7.81% | $ 197.71M |
3/31/2024 | $ 6.38M | 3.18% | $ 200.79M |
12/31/2023 | $ 5.28M | 2.74% | $ 193.01M |
9/30/2023 | $ 1.96M | 1.07% | $ 183.12M |
6/30/2023 | $ -1.3M | -0.74% | $ 175.59M |
3/31/2023 | $ -7.89M | -4.75% | $ 166.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for CYTEK BIOSCIENCES INC is calculated as follows: CF - Operations [ $ 15.16M ] / Revenues [ $ 92.84M ]
(=) OCF % [ 16.33% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |